Sleep Aids (Pharmacies) - Belgium

Revenue in the Sleep Aids market is projected to reach US$15.33m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.69%, resulting in a market volume of US$16.67m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$1.31 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Belgium is experiencing significant growth due to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Belgium are increasingly seeking sleep aids to address their sleep-related issues. The modern lifestyle, with its high levels of stress and busy schedules, has resulted in a growing number of people experiencing sleep disturbances. As a result, there is a rising demand for sleep aids to help individuals achieve better quality sleep and improve their overall well-being.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Belgium is the shift towards natural and herbal sleep aids. Consumers are becoming more conscious of the potential side effects of traditional sleep aids and are seeking alternative options that are perceived as safer and more natural. This trend is driven by a growing interest in holistic health and wellness, as well as a desire for products that are sustainable and environmentally friendly. Another trend in the market is the increasing availability of sleep aids through online channels. E-commerce platforms have gained popularity in Belgium, offering customers a convenient and discreet way to purchase sleep aids. This trend is particularly appealing to individuals who may feel uncomfortable discussing their sleep issues in person at a pharmacy.

Local special circumstances: Belgium has a well-established healthcare system with a strong emphasis on patient care. Pharmacies play a vital role in providing healthcare services to the population, including sleep aids. The accessibility and expertise of pharmacists contribute to the growth of the Sleep Aids (Pharmacies) market in Belgium. Customers trust pharmacists to provide them with appropriate advice and recommendations for sleep aids based on their individual needs.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in Belgium is also influenced by underlying macroeconomic factors. The aging population in Belgium is a significant driver of market growth, as older individuals are more likely to experience sleep-related issues. Additionally, the increasing disposable income and changing lifestyles of the population contribute to the demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in Belgium is experiencing growth due to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal sleep aids, the availability of sleep aids through online channels, the accessibility and expertise of pharmacists, the aging population, and increasing disposable income are all contributing to the development of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.